cholestyramine resin has been researched along with Nephrotic Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lloyd, JK | 1 |
| D'Amico, G; Gentile, MG | 1 |
| Kurota, M; Maeda, H; Matsuda, T; Miyaho, S; Morikawa, K; Nakai, T; Oida, K; Takahashi, S; Takai, H; Tamai, T | 1 |
| Erkelens, DW; Hené, RJ; Joles, JA; Koomans, HA; Rabelink, AJ | 1 |
| Bricker, LA | 1 |
| Edwards, KD; Neale, FC; Schapel, GJ | 1 |
| Edwards, KD; Gallt, C; Paoletti, R | 1 |
| Edwards, KD; Galli, C; Paoletti, R; Usardi, MM | 1 |
2 review(s) available for cholestyramine resin and Nephrotic Syndrome
| Article | Year |
|---|---|
Hyperlipidaemia in children.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cholestasis; Cholesterol; Cholestyramine Resin; Chylomicrons; Coronary Disease; Diabetes Complications; Electrophoresis; Fasting; Glycogen Storage Disease; Glycogen Storage Disease Type I; Humans; Hypercholesterolemia; Hyperlipidemias; Hypothyroidism; Infant; Lipoproteins; Liver Diseases; Nephrotic Syndrome; Puberty; Triglycerides; Xanthomatosis | 1975 |
A clinical approach to the hyperlipidemias.
Topics: Aluminum; Carcinoma, Hepatocellular; Cholestasis; Cholestyramine Resin; Dextrothyroxine; Diabetes Complications; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Electrophoresis; Eye Diseases; Fats, Unsaturated; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Liver Neoplasms; Myxedema; Nephrotic Syndrome; Nicotinic Acids; Triglycerides; Xanthomatosis | 1971 |
2 trial(s) available for cholestyramine resin and Nephrotic Syndrome
| Article | Year |
|---|---|
Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients.
Topics: Cholestyramine Resin; Colestipol; Food, Formulated; Gemfibrozil; Humans; Hyperlipidemias; Lipids; Lovastatin; Nephrotic Syndrome; Probucol | 1991 |
Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Random Allocation; Simvastatin | 1988 |
5 other study(ies) available for cholestyramine resin and Nephrotic Syndrome
| Article | Year |
|---|---|
[A case of familial hypercholesterolemia associated with nephrotic syndrome].
Topics: Cholestyramine Resin; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Middle Aged; Naphthalenes; Nephrotic Syndrome; Pravastatin; Prednisolone; Probucol | 1990 |
Correction of hyperlipoproteinaemia.
Topics: Cholestasis; Cholestyramine Resin; Chylomicrons; Dietary Fats; Humans; Hyperlipidemias; Hypothyroidism; Ion Exchange Resins; Lipoproteins; Nephrotic Syndrome; Progestins; Triglycerides | 1971 |
Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.
Topics: Adolescent; Adult; Alkenes; Blood Pressure; Butyrates; Cholesterol; Cholestyramine Resin; Clofibrate; Creatine Kinase; Creatinine; Female; Fluorometry; Hemoglobins; Humans; Hyperlipidemias; L-Lactate Dehydrogenase; Male; Middle Aged; Nephrotic Syndrome; Serum Albumin; Triglycerides; Tryptophan; Urate Oxidase | 1974 |
Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
Topics: Animals; Anticholesteremic Agents; Butyrates; Cholesterol; Cholestyramine Resin; Clofibrate; Female; Lipoproteins; Nephrotic Syndrome; Phosphatidylcholines; Phospholipids; Propionates; Puromycin; Rats; Serum Albumin; Triglycerides | 1970 |
Studies on the pharmacological control of hyperlipemia in experimental nephrotic syndrome.
Topics: Animals; Butyrates; Chemical and Drug Induced Liver Injury; Cholesterol; Cholestyramine Resin; Disease Models, Animal; Female; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Liver; Nephrotic Syndrome; Nucleosides; Organ Size; Phosphatidylcholines; Phospholipids; Propionates; Puromycin; Rats; Thyroxine; Triglycerides | 1970 |